[1. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics 2014 update: a report from the American Heart Association. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2014; 129: 280-292.]Search in Google Scholar
[2. Ho KK, Pinsky JL, Kannel WB, et al. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993; 22: 6–13.10.1016/0735-1097(93)90455-A]Open DOISearch in Google Scholar
[3. McMurray JJ, Adamopuulus S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology Deloped in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012; 33: 1787–847.10.1093/eurheartj/ehs104]Search in Google Scholar
[4. Yancy CW, Jessup M, Bozkurt B, et al. ACCF/AHA Guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation 2013; 128: 240-327.10.1161/CIR.0b013e31829e8776]Search in Google Scholar
[5. Aronov DM. Importance of coenzyme Q10 in cardiology. Russian Medical Journal, 2007; 15: 1484-1488.]Search in Google Scholar
[6. Fotino AD, Thompson-Paul AM, Bazzano LA. Effect of coenzyme Q10 supplementation on heart failure: a meta-analysis. Am J Clin Nutr 2013; 97: 268–275.10.3945/ajcn.112.040741]Search in Google Scholar
[7. Mortensen SA. Coenzyme Q10: will this natural substance become a guideline-directed adjunctive therapy in heart failure? JACC Heart Fail 2015; 3:270-271.10.1016/j.jchf.2014.12.006]Search in Google Scholar
[8. Miles MV, Horn PS, Tang PH, et al. Age-related changes in plasma coenzyme Q10 concentrations and redox state in apparently healthy children and adults. AJ Clin Chim Acta 2004; 347: 139-144.10.1016/j.cccn.2004.04.003]Search in Google Scholar
[9. Medvedev OS, Kalenikova EI, Gorodetzkaya EA, et al. Coenzyme Q10 in cardiology practice – theoretical bases and clinical studies results. Russian Medical Journal, 2009; 17: 1177-1181.]Search in Google Scholar
[10. R. Ferrari, L. Agnoletti, L. Comini, G. et al. Oxidative stress during myocardial ischemia and heart failure, Eur Heart J 1998; 19:2–11.]Search in Google Scholar
[11. Sarah L. Molyneux, Christopher M, et al. Coenzyme Q10 An Independent Predictor of Mortality in Chronic Heart Failure Christchurch, New Zealand. J Am Coll Caqrdiol 2008; 52: 1435-1441.]Search in Google Scholar
[12. Madamanchi NR, Runge MS. Mitochondrial dysfunction in atherosclerosis. Circ Res. 2007; 100: 460–473.10.1161/01.RES.0000258450.44413.96]Open DOISearch in Google Scholar
[13. Ponikowski P, Voors AA, Anker SD et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology. Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016, 20.10.1093/eurheartj/ehw128]Search in Google Scholar
[14. Berezin AE. Biological markers in chronic heart failure: hopes, reality, perspectives. Serceva nedostatnist 2013; 1:5-15.]Search in Google Scholar
[15. Tsutamoto T. Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1. Eur Heart J 199; 20: 1799-1807.10.1053/euhj.1999.1746]Search in Google Scholar
[16. Soja AM, Mortensen SA. Treatment of congestive heart failure with coenzyme Q 10 illuminated by meta-analyses of clinical trials. Mol Aspects Med 1997; 18: 159–168.10.1016/S0098-2997(97)00042-3]Search in Google Scholar
[17. Sander S, Coleman CI, Patel AA, et al. The impact of coenzyme Q10 on systolic function in patients with chronic heart failure. J Card Fail 2006; 12: 464–472.10.1016/j.cardfail.2006.03.00716911914]Search in Google Scholar
[18. Judy WV, Hall JH, Toth PD, et al. Double blind-double crossover study of coenzyme Q10 in heart failure, in: Biomedical and Clinical Aspects of Coenzyme Q, Vol. 5. K. Folkers and Y. Yamamura, eds, Elsevier, Amsterdam 1986, pp. 315–323.]Search in Google Scholar
[19. Munkholm H, Hansen HHT, Rasmussen K. Coenzyme Q10 treatment in serious heart failure. Ann Intern Med 1999; 9: 285–289.10.1002/biof.5520090225]Search in Google Scholar
[20. Wolsk E, Claggett B, Pfeffer MA, et al. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus. J Am Heart Assoc. 2017; 6: 43-47.10.1161/JAHA.116.004743566914628554908]Search in Google Scholar
[21. Edlund PO. Determination of coenzyme Q10, α-tocopherol and cholesterol in biological samples by coupled-column liquid chromatography with coulometric and ultraviolet detection. J Chromatogr 1988; 425: 87–97.10.1016/0378-4347(88)80009-4]Search in Google Scholar
[22. Rosenfeldt FL, Haas SJ, Krum H, et al. Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. J Hum Hypertens 2007; 21:297-306.10.1038/sj.jhh.1002138]Search in Google Scholar
[23. Gorokhova SG, Sizova ZM. Pharmacotherapy of chronic heart failure in ambulatory practice. Physician’s workbook. Medpraktika-M 2008; pp.85.]Search in Google Scholar
[24. Mortensen SA, Rosenfeldt F, Kumar A, et al. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial. JACC Heart Fail. 2014; 2:641–649.10.1016/j.jchf.2014.06.008]Search in Google Scholar
[25. Keogh A, Fenton S, Leslie C, et al. Randomized doubleblind, placebo-controlled trial of coenzyme Q10 therapy in class II and III systolic heart failure. Heart Lung Circ. 2003; 12:135–141.10.1046/j.1443-9506.2003.00189.x]Search in Google Scholar
[26. DiNicolantonio JJ, Bhutani J, McCarty MF, et al. Coenzyme Q10 for the treatment of heart failure: a review of the literature. Open Heart 2015; 2: 32-36.10.1136/openhrt-2015-000326]Search in Google Scholar
[27. Alehagen U, Johansson P, Bjornstedt M, et al. Cardiovascular mortality and N-terminal-proBNP reduced after combined selenium and coenzyme Q10 supplementation: a 5-year prospective randomized doubleblind placebo-controlled trial among elderly Swedish citizens. Int J Cardiol. 2013; 167:1860-1866.10.1016/j.ijcard.2012.04.156]Search in Google Scholar
[28. Sizova ZM, Farafoniva TN, Medvedev OS, et al. Possibilities of different doses coenzyme Q10 administration in patients with chronic heart failure. Heart failure 2010; 11: 218-222.]Search in Google Scholar
[29. Tokareva OG, Kharitonova EV, Mareev VY, et al. Vliyanie koenzima Q10 v sostave standartnoj terapii bolnyx xronicheskoj serdechnoj nedostatochnostyu na plazmennye urovni mozgovogo natrijureticheskogo peptida. Zhurnal Serdechnaya Nedostatochnost 2014; 850: 232–237.]Search in Google Scholar
[30. Jankowski J, Korzeniowska K, Cieslewicz A, et al. Coenzyme Q10 - A new player in the treatment of heart failure? Pharmacol Rep 2016; 68: 1015-1019.10.1016/j.pharep.2016.05.012]Search in Google Scholar
[31. Lampertico M, Comis S. Italian multicenter study on the efficacy and safety of coenzyme Q10 as adjuvant therapy in heart failure. Clin Investig. 1993; 71: 129-133.10.1007/BF00226853]Search in Google Scholar
[32. Fotino AD, Thompson-Paul AM, Bazzano LA. Effect of coenzyme Q10 supplementation on heart failure: a meta-analysis. Am J Clin Nutr 2013; 97: 268-75.10.3945/ajcn.112.040741]Search in Google Scholar
[33. Morisco C, Trimarco B, Condorelli M. Effect of coenzyme Q10 therapy in patients with congestive heart failure: a long-term multicenter randomized study. Clin Investig. 1993; 71: 134–136.10.1007/BF00226854]Search in Google Scholar
[34. Crane FL, Hatefi Y, Lester RL, et al. Isolation of a quinone from beef heart mitochondria. Biochim Biophys Acta 1957; 25: 220–1.10.1016/0006-3002(57)90457-2]Open DOISearch in Google Scholar
[35. Mellors A, Tappel AL. The inhibition of mitochondrial peroxidation by ubiquinone and ubiquinol. J Biol Chem 1966; 241: 4353–4356.10.1016/S0021-9258(18)99728-0]Search in Google Scholar